Encompass Health (EHC) is set to release its latest quarterly earnings report on Monday, October 28th. Analysts anticipate strong performance, but investors should consider the company’s recent track record and peer comparisons before making any investment decisions. This article provides a comprehensive overview of Encompass Health’s financial performance and market positioning, along with insights into analyst expectations and key metrics to watch.
Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, reported strong results for the first quarter ended March 31, 2024.
Revenue grew by 13.4% to $1.4 billion, driven primarily by strong discharge growth. Adjusted EBITDA increased by 19.2% to $300.9 million. The Company increased its full-year guidance for Adjusted EBITDA and adjusted earnings per share.
Mark Tarr, President and Chief Executive Officer of Encompass Health, said, “We are pleased with our first-quarter performance. Revenue growth of 13.4% driven primarily by strong discharge growth combined with prudent expense management to drive Adjusted EBITDA growth of 19.2%. Our value proposition and operating strategy continue to be validated and we remain highly optimistic about the long-term prospects of our business.”
